{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:44:31Z","timestamp":1791045871217,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06136-9","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:40:59Z","timestamp":1769697659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using intravesical botulinum toxin as an adjunct during urologic surgery: a systematic review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-3173","authenticated-orcid":false,"given":"Suditi","family":"Rahematpura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Marantidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wibben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Kalaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael D.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"6136_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0022-5347(17)42717-0","volume":"139","author":"DD Dykstra","year":"1988","unstructured":"Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139:919\u2013922. https:\/\/doi.org\/10.1016\/s0022-5347(17)42717-0","journal-title":"J Urol"},{"key":"6136_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ncpuro1124","volume":"5","author":"MB Chancellor","year":"2008","unstructured":"Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Aoki KR (2008) Drug insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5:319\u2013328. https:\/\/doi.org\/10.1038\/ncpuro1124","journal-title":"Nat Clin Pract Urol"},{"key":"6136_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005493.pub3","author":"JB Duthie","year":"2011","unstructured":"Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005493.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"6136_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159307","volume":"11","author":"T Cheng","year":"2016","unstructured":"Cheng T, Shuang W-B, Jia D-D, Zhang M, Tong X-N, Yang W-D, Jia X-M, Li S (2016) Efficacy and safety of OnabotulinumtoxinA in patients with neurogenic detrusor overactivity: a systematic review and meta-analysis of randomized controlled trials. PLoS One 11:e0159307. https:\/\/doi.org\/10.1371\/journal.pone.0159307","journal-title":"PLoS One"},{"key":"6136_CR5","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1016\/j.juro.2016.10.109","volume":"197","author":"VW Nitti","year":"2017","unstructured":"Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C, EMBARK Study Group (2017) OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol 197:S216\u2013S223. https:\/\/doi.org\/10.1016\/j.juro.2016.10.109","journal-title":"J Urol"},{"key":"6136_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.urology.2018.11.037","volume":"125","author":"HY Lee","year":"2019","unstructured":"Lee HY, Doo SW, Yang WJ, Song YS, Sun HY, Nho EJ, Lee B, Kim JH (2019) Efficacy and safety of noninvasive intravesical instillation of onabotulinum Toxin-A for overactive bladder and interstitial cystitis\/bladder pain syndrome: systematic review and meta-analysis. Urology 125:50\u201357. https:\/\/doi.org\/10.1016\/j.urology.2018.11.037","journal-title":"Urology"},{"key":"6136_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003985","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ et al (2024) The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000003985","journal-title":"J Urol"},{"key":"6136_CR8","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/nau.25037","volume":"41","author":"J Zillioux","year":"2022","unstructured":"Zillioux J, Welk B, Suskind AM, Gormley EA, Goldman HB (2022) SUFU white paper on overactive bladder anticholinergic medications and dementia risk. Neurourol Urodyn 41:1928\u20131933. https:\/\/doi.org\/10.1002\/nau.25037","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 3","key":"6136_CR9","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/nau.22637","volume":"33","author":"E Rovner","year":"2014","unstructured":"Rovner E (2014) Practical aspects of administration of onabotulinumtoxinA. Neurourol Urodyn 33(Suppl 3):S32-37. https:\/\/doi.org\/10.1002\/nau.22637","journal-title":"Neurourol Urodyn"},{"key":"6136_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/CPAA.S256051","volume":"12","author":"F Allameh","year":"2020","unstructured":"Allameh F, Basiri A, Razzaghi M, Abedi AR, Fallah-Karkan M, Ghiasy S, Hosseininia SM, Montazeri S (2020) Clinical efficacy of transurethral resection of the prostate combined with oral anticholinergics or botulinum toxin - A injection to treat benign prostatic hyperplasia with overactive bladder: a case-control study. Clin Pharmacol Adv Appl 12:75\u201381. https:\/\/doi.org\/10.2147\/CPAA.S256051","journal-title":"Clin Pharmacol Adv Appl"},{"key":"6136_CR11","first-page":"228","volume":"11","author":"F Allameh","year":"2023","unstructured":"Allameh F, Hosseininia M, Karimi Rouzbahani A, Narouie B, Dadpour M (2023) Efficacy of botulinum toxin-A injection versus oral anticholinergic medications following transurethral resection of the prostate to manage bladder outlet obstruction with overactive bladder: a prospective randomized clinical trial study. Am J Clin Exp Urol 11:228\u2013234","journal-title":"Am J Clin Exp Urol"},{"key":"6136_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1089\/end.2023.0074","volume":"37","author":"MM Huang","year":"2023","unstructured":"Huang MM, Dean NS, Assmus MA, Lee MS, Guo JN, Krambeck AE (2023) Intradetrusor OnabotulinumtoxinA injections at the time of holmium laser enucleation of the prostate for men with severe storage symptoms. J Endourol 37:801\u2013806. https:\/\/doi.org\/10.1089\/end.2023.0074","journal-title":"J Endourol"},{"key":"6136_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1590\/S1677-55382008000100010","volume":"34","author":"P Patki","year":"2008","unstructured":"Patki P, Woodhouse JB, Patil K, Hamid R, Shah J (2008) An effective day case treatment combination for refractory neuropathic mixed incontinence. Int Braz J Urol 34:63\u201372. https:\/\/doi.org\/10.1590\/S1677-55382008000100010","journal-title":"Int Braz J Urol"},{"key":"6136_CR14","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4584","author":"Z Petrovic","year":"2010","unstructured":"Petrovic Z, M\u00fcller L (2010) Surgical therapy of mixed incontinence in women. Eur Urol Suppl. https:\/\/doi.org\/10.5489\/cuaj.4584","journal-title":"Eur Urol Suppl"},{"key":"6136_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/gyn.2012.0134","volume":"29","author":"MK Shirvan","year":"2013","unstructured":"Shirvan MK, Noughabi SAS, Rahimi HR (2013) Tension-free vaginal tape plus intradetrusor BOTOX\u00ae injection versus tension-free vaginal tape versus intradetrusor BOTOX injection in equal-weight mixed urinary incontinence: a prospective randomized study. J Gynecol Surg 29:235\u2013240. https:\/\/doi.org\/10.1089\/gyn.2012.0134","journal-title":"J Gynecol Surg"},{"key":"6136_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12060365","volume":"12","author":"Y-H Chang","year":"2020","unstructured":"Chang Y-H, Hsiao P-J, Chi-Ping H, Wu H-C, Hsieh P-F, Chou EC-L (2020) A comparative observational study to evaluate the efficacy of mid-urethral sling with botulinum toxin A injection in urinary incontinence patients. Toxins 12:365. https:\/\/doi.org\/10.3390\/toxins12060365","journal-title":"Toxins"},{"key":"6136_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/AOG.0000000000004198","volume":"137","author":"A Komar","year":"2021","unstructured":"Komar A, Bretschneider CE, Mueller MG, Lewicky-Gaupp C, Collins S, Geynisman-Tan J, Tavathia M, Kenton K (2021) Concurrent retropubic midurethral sling and OnabotulinumtoxinA for mixed urinary incontinence: a randomized controlled trial. Obstet Gynecol 137:12\u201320. https:\/\/doi.org\/10.1097\/AOG.0000000000004198","journal-title":"Obstet Gynecol"},{"key":"6136_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/nau.24797","volume":"41","author":"S Hajebrahimi","year":"2022","unstructured":"Hajebrahimi S, Shamsi-Sisi H, Jahantabi E, Salehi-Pourmehr H, Hashim H (2022) Efficacy of combination therapy of mid-urethral sling and low-dose Abobotulinumtoxin-A injection in mixed urinary incontinence. Neurourol Urodyn 41:211\u2013219. https:\/\/doi.org\/10.1002\/nau.24797","journal-title":"Neurourol Urodyn"},{"key":"6136_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8579","volume":"12","author":"D Hamidi Alamdari","year":"2024","unstructured":"Hamidi Alamdari D, Douzandeh A, Keshvari Shirvan M, Narouie B, Radpour N (2024) Mixed treatment for same-severe mixed urinary incontinence: a novel method. Clin Case Rep 12:e8579. https:\/\/doi.org\/10.1002\/ccr3.8579","journal-title":"Clin Case Rep"},{"key":"6136_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.urology.2018.04.006","volume":"118","author":"ME Fuchs","year":"2018","unstructured":"Fuchs ME, Beecroft N, McLeod DJ, Dajusta DG, Ching CB (2018) Intraoperative onabotulinumtoxin-A reduces postoperative narcotic and anticholinergic requirements after continent bladder reconstruction. Urology 118:183\u2013188. https:\/\/doi.org\/10.1016\/j.urology.2018.04.006","journal-title":"Urology"},{"key":"6136_CR21","unstructured":"DailyMed-BOTOX-onabotulinumtoxina injection, powder, lyophilized, for solution. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=33d066a9-34ff-4a1a-b38b-d10983df3300. Accessed 17 Sep 2025"},{"key":"6136_CR22","unstructured":"Nel F, Mierzwinski R, Conradie M\u00a0(2006) Laparoscopic bladder autoaugmentation combined with intravesical botox injection for treatment of poorly compliant bladder and urge type of urinary incontinence: initial report.\u00a0J EndouroL. 20: A120"},{"key":"6136_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2022.102307","volume":"46","author":"E Sirls","year":"2023","unstructured":"Sirls E, Peters KM, Sirls LT (2023) Intradetrusor onabotuliniumtoxinA injection for refractory bladder spasms before vesicovaginal fistula repair. Urol Case Rep 46:102307. https:\/\/doi.org\/10.1016\/j.eucr.2022.102307","journal-title":"Urol Case Rep"},{"key":"6136_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.urology.2018.08.009","volume":"122","author":"JS Fuchs","year":"2018","unstructured":"Fuchs JS, Shakir N, McKibben MJ, Scott JM, Viers B, Pagliara T, Morey AF (2018) Changing trends in reconstruction of complex anterior urethral strictures: from skin flap to perineal urethrostomy. Urology 122:169\u2013173. https:\/\/doi.org\/10.1016\/j.urology.2018.08.009","journal-title":"Urology"},{"key":"6136_CR25","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.juro.2009.01.037","volume":"181","author":"JM Wu","year":"2009","unstructured":"Wu JM, Siddiqui NY, Amundsen CL, Myers ER, Havrilesky LJ, Visco AG (2009) Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence. J Urol 181:2181\u20132186. https:\/\/doi.org\/10.1016\/j.juro.2009.01.037","journal-title":"J Urol"},{"key":"6136_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00192-018-3653-z","volume":"29","author":"JP Shepherd","year":"2018","unstructured":"Shepherd JP, Carter-Brooks CM, Chermanksy C (2018) A cost-effectiveness analysis of onabotulinumtoxin A as first-line treatment for overactive bladder. Int Urogynecol J 29:1213\u20131219. https:\/\/doi.org\/10.1007\/s00192-018-3653-z","journal-title":"Int Urogynecol J"},{"key":"6136_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168743","volume":"18","author":"H Shabir","year":"2021","unstructured":"Shabir H, Hashemi S, Al-Rufayie M, Adelowo T, Riaz U, Ullah U, Alam B, Anwar M, de Preux L (2021) Cost-utility analysis of oxybutynin vs. onabotulinumtoxinA (Botox) in the treatment of overactive bladder syndrome. Int J Environ Res Public Health 18:8743. https:\/\/doi.org\/10.3390\/ijerph18168743","journal-title":"Int J Environ Res Public Health"},{"key":"6136_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/JU.0000000000002804","volume":"208","author":"MF Malcher","year":"2022","unstructured":"Malcher MF, Droupy S, Berr C, Ziad A, Huguet H, Faillie J-L, Serrand C, Mura T (2022) Dementia associated with anticholinergic drugs used for overactive bladder: a nested case-control study using the French National Medical-Administrative database. J Urol 208:863\u2013871. https:\/\/doi.org\/10.1097\/JU.0000000000002804","journal-title":"J Urol"},{"key":"6136_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/JU.0000000000004660","volume":"214","author":"M-H Hsieh","year":"2025","unstructured":"Hsieh M-H, Hwang J-C, Su T-H, Lau H-H (2025) The efficacy and safety between intradetrusor OnabotulinumtoxinA injection and combined pharmacotherapy in patients with refractory overactive bladder: a randomized controlled trial. J Urol 214:344\u2013353. https:\/\/doi.org\/10.1097\/JU.0000000000004660","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06136-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:41:03Z","timestamp":1769697663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06136-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6136"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06136-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No human participants were involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"No IRB approval was required for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval"}}],"article-number":"134"}}